Apple Health (Medicaid): Provider Alert
Dear Provider,
Retroactive for claims with dates of service on and after June 1, 2017, the Health Care Authority (agency) is correcting an error in the Apple Health (Medicaid): Fee-for- Service Preferred Drug List (PDL):
Drug Class
|
Drug Name
|
Change
|
Diabetes Drugs -- Long-Acting Insulins
|
Basaglar Kwikpen®
|
Basaglar Kwikpen® was listed incorrectly as Preferred. The agency has changed it to Non-Preferred and added the drug to the “What is new?” list for June 1. Prior authorization is required.
|
For more details, see the agency’s Apple Health Medicaid: Fee-for-Service Preferred Drug List.
|